Aurinia Pharmaceuticals Inc.
USD17.16
+0.37 (+2.20%)
CEO
Kevin C. Tang
IPO Date
2014-09-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$17.36
Prev. Close
$16.79
Day Low
$16.87
Day High
$17.36
52W Low
$7.29
52W High
$19.25
Market Cap
$2.21B
Volume
0.20M
| 223.3 |
| 31 Dec 2023 | FY | 91.9% | -44.5% | -20.6% | -14.2% | 0.26 | 5.50 | -16.5 |
| 31 Dec 2022 | FY | 95.8% | -80.7% | -26.7% | -23.0% | 0.02 | 9.60 | -5.7 |
| 31 Dec 2021 | FY | 97.6% | -396.8% | -37.8% | -33.3% | 0.02 | 12.63 | -16.3 |
| 31 Dec 2020 | FY | 100.0% | -204.9% | -25.2% | -22.1% | 0.02 | 13.11 | -16.0 |
| 31 Dec 2019 | FY | 100.0% | -27794.0% | -29.6% | -27.3% | 0.00 | 27.90 | -21.3 |
| 31 Dec 2018 | FY | -8837.8% | -13848.8% | -57.0% | -44.0% | 0.00 | 18.30 | -9.0 |
| 31 Dec 2017 | FY | 99.8% | -16855.2% | -42.7% | -37.3% | 0.00 | 21.50 | -5.3 |
| 31 Dec 2016 | FY | 97.7% | -13465.3% | -64.8% | -40.9% | 0.00 | 5.22 | -3.2 |
| 2.5 |
| 30 Sept 2025 | Q3 | 88.4% | 42.9% | 8.6% | 6.0% | 0.21 | 5.76 | 12.0 |
| 30 Jun 2025 | Q2 | 89.8% | 30.7% | 6.4% | 4.3% | 0.24 | 5.23 | 13.7 |
| 31 Mar 2025 | Q1 | 86.3% | 37.4% | 6.7% | 4.6% | 0.22 | 5.93 | 12.0 |
| 31 Dec 2024 | Q4 | 90.7% | 2.4% | 0.4% | 0.3% | 0.21 | 4.57 | 223.4 |
| 30 Sept 2024 | Q3 | 91.1% | 21.2% | 3.7% | 2.6% | 0.23 | 5.60 | 18.3 |
| 30 Jun 2024 | Q2 | 84.4% | 1.3% | 0.2% | 0.1% | 0.24 | 5.33 | 272.5 |
| 31 Mar 2024 | Q1 | 84.6% | -21.4% | -3.0% | -2.1% | 0.25 | 5.60 | -18.1 |
| 31 Dec 2023 | Q4 | 88.0% | -59.6% | -7.1% | -4.9% | 0.26 | 5.50 | -12.0 |